An expert discusses how long-term safety considerations are evaluated through clinical trial data and postmarketing ...

Miriam Freimer, MD, clinical professor of neurology at The Ohio State University Wexner Medical Center, reflects on how findings from the RAISE-XT trial potentially translate to real-world practice ...

The Supreme Court decision in Medina v Planned Parenthood South Atlantic and the subsequent passing of the budget bill leave ...

The 16-person, first-in-human study showed promising safety and efficacy data for delivering insulin intranasally in older ...

Flatiron Health expands its international oncology research network, enhancing real-world data use to improve patient ...

Brentuximab vedotin combined with cyclophosphamide, doxorubicin, and prednisone (CHP) shows promising results as a first-line ...

The rapidly increasing prescriptions for expensive specialty medications, rather than their price growth, are the primary ...

The potential of health care technology has been disconnected from patients, making those innovations barriers rather than means of improving access and communication.

Rebecca Chacko, MD, discusses key breast cancer care challenges, including treatment access delays and the importance of open patient communication, as highlighted at the Detroit Institute for ...

Amir Fathi, MD, discusses one of the biggest nonfinancial barriers to bispecific therapies: the expertise required to safely ...

Panelists discuss how subcutaneous (SubQ) and intravenous (IV) oncology therapies will continue to coexist, with ...

Panelists discuss how challenges such as extended nursing workflow, patient hesitancy, limited formulation indications, ...